News

News-Medical.Net on MSN5d
Patients with asthma reminded of the increased risk of severe asthma attacks from overusing blue inhalers
This reminder follows updates to product information and the National Institute for Health and Care Excellence (NICE) ...
Autolus Therapeutics confirms license of Aucatzyl issued by U.K. MHRA
Autolus Therapeutics (AUTL) confirmed that the U.K. Medicines and Healthcare products Regulatory Agency has granted conditional marketing ...
pharmaphorum2d
Three NICE thresholds for cost-effectiveness: does that make sense?
A consultation from the National Institute for Health and Care Excellence (NICE) and NHS England (NHSE) has proposed what amounts to an explicit, third threshold for cost-effectiveness to be used ...
Pharmabiz6d
Pharming receives positive recommendation from NICE for Joenja to treat APDS in adult and paediatric patients 12 years of age and older
Pharming Group N.V. (Pharming), a global biopharmaceutical company, announces that the National Institute for Health and Care Excellence (NICE) has issued positive final guidance recommending Joenja ...
LBC6d
Health chiefs issue warning to anyone who users an asthma inhaler
It comes after the National Institute for Health and Care Excellence (Nice) updated its guidance on salbutamol and terbutaline, which are used to relieve sudden asthma symptoms. Nice now recommends ...
The Independent5d
Pill that slashes risk of breast cancer recurring to be available on NHS
The decision by the National Institute for Health and Care Excellence (Nice) is expected to benefit about 4,000 people. Ribociclib (known by the brand name Kisqali), manufactured by Novartis ...
pharmaphorum3d
NICE recommends first CAR-T cell therapy on NHS in England
Gilead Sciences and Kite, a Gilead company, have announced that the National Institute for Health and Care Excellence (NICE) has recommended Yescarta (axicabtagene ciloleucel; axi-cel) for routine ...
Finanznachrichten7d
Pharming Group N.V.: Pharming receives positive recommendation from NICE for Joenja?(leniolisib) as a treatment for APDS
announces that the National Institute for Health and Care Excellence (NICE) has issued positive final guidance recommending Joenja® (leniolisib) for reimbursement and use within the National ...
News Medical5d
Healthcare News
This reminder follows updates to product information and the National Institute for Health and Care Excellence (NICE) guidance for short-acting beta 2 agonists (SABAs), including salbutamol and ...
Manchester Evening News6d
Warning to anyone who uses an asthma inhaler more than twice a week
The warning follows updates to product information and the National Institute for Health and Care Excellence (NICE) guidance for short-acting beta 2 agonists (SABAs), including salbutamol and ...
Bristol Post6d
Health chiefs issue urgent warning to all asthma sufferers with 'blue inhaler'
This reminder follows updates to product information and the National Institute for Health and Care Excellence (NICE) guidance for short-acting beta 2 agonists (SABAs), including salbutamol and ...